Zuzana Střížová - Concepedia

Author

Zuzana Střížová

Also Known As

Z Ozaniak Střížová, Z STRIZOVA, Z Strizova, Z Střížová, Z. Ozaniak Strizova, Z. Ozaniak Střížová, Z. Strizova, Z., Strizova, Z.O. Ozaniak Strizova, Zuzana Ozaniak Strizova

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University Hospital in Motol Charles University Institute of Clinical and Experimental Medicine

About

Zuzana Střížová is an author at University Hospital in Motol specializing in medicine, immunology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	123
2	Immunology	6	6	105
3	Pathology	3	3	51
4	Public Health	1	1	21
5	Epidemiology	1	1	21

Zuzana Střížová

Publications

686

Citations

H-Index

Page 1

	Year	Citations
M1/M2 macrophages and their overlaps – myth or reality? Zuzana Střížová, Iva Benešová, Robin Bartolini, Clinical Science	2023	449
The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro Dmitry Stakheev, Pavla Táborská, Zuzana Střížová, Scientific Reports	2019	64
The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients Zuzana Střížová, Martin Snajdauf, Dmitry Stakheev, Journal of Cancer Research and Clinical Oncology Tumor ImmunologyEsophageal CancerCancer ImmunosurveillanceMedicineImmunology	2020	22
Can wearing face masks in public affect transmission route and viral load in COVID-19? Zuzana Střížová, Jiřina Bartůňková, Daniel Smrž Central European Journal of Public Health VaccinationMucosal VaccinationFace MasksViral LoadContact Tracing	2020	21
NK and T cells with a cytotoxic/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma Zuzana Střížová, Pavla Táborská, Dmitry Stakheev, Urologic Oncology Seminars and Original Investigations Cytotoxic/migratory Phenotype AccumulateUrologyCancer ImmunosurveillanceGenitourinary CancerImmunology	2019	19
Extended ischemic time (>15 hours) using controlled hypothermic storage in lung transplantation: A multicenter experience René Novysedlák, An‐Lies Provoost, Nathaniel B. Langer, The Journal of Heart and Lung Transplantation TransplantationMedicineHypothermic StorageIschemic TimeOrgan Preservation	2024	18
Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab Jitka Smetanová, Zuzana Střížová, Anna Šedivá, The Lancet Rheumatology InflammationRheumatologyAutoimmune DiseaseSpondyloarthritisHumoral Response	2021	17
A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade Andrej Ozaniak, Jitka Smetanová, Robin Bartolini, Journal of Cancer Research and Clinical Oncology Tumor ImmunologyAnti-pd-1 BlockadeCancer ImmunosurveillanceImmunologyTherapeutic Vaccine	2022	16
SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors Pavla Táborská, Jan Lašťovička, Dmitry Stakheev, Immunity Inflammation and Disease	2021	15
Tumoral and paratumoral NK cells and CD8+ T cells of esophageal carcinoma patients express high levels of CD47 Zuzana Střížová, J Vachtenheim, Martin Snajdauf, Scientific Reports	2020	14

Page 1